Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 21, 2026 07:25 ET | Source: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

MELBOURNE, Australia and SAN FRANCISCO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
January 21, 2026 07:00 ET | Source: Matrix Service Company

Matrix Service Company Sets Dates for Release of Second Quarter Fiscal 2026 Financial Results and Conference Call

TULSA, Okla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX), a leading provider of engineering and construction services to the energy and industrial markets, announced...
January 21, 2026 07:00 ET | Source: Lisata Therapeutics, Inc.

Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer

Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestones Offer represents an approximate 85% premium...
January 21, 2026 07:00 ET | Source: Ocular Therapeutix, Inc.

Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA® while at Regeneron Most recently served as Chief...
January 21, 2026 07:00 ET | Source: Mobix Labs, Inc.

Mobix Labs and Peraso Engage in Further Discussions Regarding a Potential Strategic Transaction

IRVINE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”), a rapidly growing fabless semiconductor and connectivity company serving the defense, aerospace, and...
January 21, 2026 07:00 ET | Source: Skye Bioscience, Inc.

Skye Bioscience to Present Poster at Keystone Obesity Conference

SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other...
January 21, 2026 07:00 ET | Source: Old National Bancorp

Old National Bancorp Reports Fourth Quarter and Full-Year 2025 Results

EVANSVILLE, Ind., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Old National Bancorp (NASDAQ: ONB) reports 4Q25 net income applicable to common shares of $212.6 million, diluted EPS of $0.55; $241.0 million and...
January 21, 2026 07:00 ET | Source: WeShop Holdings Limited

WeShop Announces Retail Partnerships with Booking.com, Hertz, Avis, Expedia, and Others Ahead of Peak Winter Travel Season

NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, today announced retail...
January 21, 2026 07:00 ET | Source: Exicure, Inc.

Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

REDWOOD CITY, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it...
January 21, 2026 07:00 ET | Source: Beneficient

Beneficient Announces Final Court Approval of GWG Litigation Settlement

Beneficient announced that the U.S. District Court has approved the previously disclosed settlement of the lawsuits relating to GWG Holdings, Inc.